IGC Pharma

IGC Pharma(IGC)

POTOMAC, MD
Pharmaceutical

Focus: Cannabinoid for Alzheimer's

IGC Pharma is a life sciences company focused on Cannabinoid for Alzheimer's.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Edutainment Content: Norms Campaign
Intimate Partner Violence (IPV)
N/A
Clinical Trials (1)
NCT06916377The Economics of Domestic Violence: Evidence From Bangladesh
N/A
Exposure
COVID-19
N/A
Clinical Trials (1)
NCT04370808VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection
N/A
Clinical Trials (1)
NCT04749563Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease
Phase 1
IGC-AD1-Active
Alzheimer Disease
Phase 2
Clinical Trials (1)
NCT05543681Clinical Trial on Agitation in Alzheimer's Dementia
Phase 2

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts
Portfolio: 4 clinical trials
SEC Filings: 2 available

Financials (FY2025)

Revenue
$1M48%
R&D Spend
$4M(281%)9%
Net Income
-$13M
Cash
$1M